• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

食管鳞癌的治疗管理

Managing Squamous Cell Esophageal Cancer.

机构信息

Department of Surgery, University of Nebraska Medical Center, 983280 Nebraska Medical Center, Omaha, NE 68198, USA.

Internal Medicine, Division of Gastroenterology-Hepatology, 982000 Nebraska Medical Center, Omaha, NE 68198-2000, USA.

出版信息

Surg Clin North Am. 2019 Jun;99(3):529-541. doi: 10.1016/j.suc.2019.02.006. Epub 2019 Mar 27.

DOI:10.1016/j.suc.2019.02.006
PMID:31047040
Abstract

This article reviews the pathophysiology, risk factors, clinical presentation/diagnosis, and management of SCC.

摘要

本文回顾了 SCC 的病理生理学、危险因素、临床表现/诊断和治疗。

相似文献

1
Managing Squamous Cell Esophageal Cancer.食管鳞癌的治疗管理
Surg Clin North Am. 2019 Jun;99(3):529-541. doi: 10.1016/j.suc.2019.02.006. Epub 2019 Mar 27.
2
Multidisciplinary Therapy of Esophageal Cancer.食管癌的多学科治疗。
Surg Clin North Am. 2019 Jun;99(3):419-437. doi: 10.1016/j.suc.2019.02.002. Epub 2019 Mar 30.
3
Definitive or neoadjuvant chemoradiotherapy for squamous cell oesophageal cancer?鳞状细胞食管癌的根治性或新辅助放化疗？
Lancet Oncol. 2018 Oct;19(10):1285-1286. doi: 10.1016/S1470-2045(18)30662-4. Epub 2018 Oct 1.
4
[Diagnosis and treatment of early esophageal squamous cell carcinoma and precancerous lesions].早期食管鳞状细胞癌及癌前病变的诊断与治疗
Zhonghua Nei Ke Za Zhi. 2020 Apr 1;59(4):318-321. doi: 10.3760/cma.j.cn112138-20200210-00061.
5
Cancer stem cells in esophageal cancer and response to therapy.食管癌中的癌症干细胞及其对治疗的反应。
Cancer. 2018 Oct 15;124(20):3962-3964. doi: 10.1002/cncr.31697. Epub 2018 Oct 25.
6
Prognosis of Interval Distant Metastases After Neoadjuvant Chemoradiotherapy for Esophageal Cancer.新辅助放化疗后食管癌间隔远处转移的预后。
Ann Thorac Surg. 2022 Feb;113(2):482-490. doi: 10.1016/j.athoracsur.2021.01.061. Epub 2021 Feb 18.
7
Nomograms to predict survival rates for esophageal cancer patients with malignant behaviors based on ICD-0-3.基于 ICD-0-3 的恶性行为食管癌患者生存率预测列线图
Future Oncol. 2019 Jan;15(2):121-132. doi: 10.2217/fon-2018-0493. Epub 2018 Sep 20.
8
Efficacy and Safety of Neoadjuvant Chemoradiotherapy Following Esophagectomy with Japanese-style Extended 3-Field Lymphadenectomy for Thoracic Esophageal Cancer.食管癌根治术联合日本式扩大三野淋巴结清扫术后新辅助放化疗的疗效与安全性
Anticancer Res. 2017 Oct;37(10):5837-5843. doi: 10.21873/anticanres.12027.
9
Impact of Interval Between Neoadjuvant Chemoradiation and Surgery Upon Morbidity and Survival of Patients with Squamous Cell Carcinoma of Thoracic Esophagus.新辅助放化疗与手术间隔时间对胸段食管癌鳞状细胞癌患者发病率和生存率的影响
Anticancer Res. 2018 Sep;38(9):5239-5245. doi: 10.21873/anticanres.12848.
10
Esophageal squamous cell carcinoma and adenocarcinoma: At the Gates of Mordor.食管鳞状细胞癌和腺癌：在魔多之门（注：这里“魔多之门”是一种形象化表述，可根据具体语境理解其含义，比如比喻病情严重程度或治疗困难程度等类似情境）
J Thorac Cardiovasc Surg. 2017 Oct;154(4):1444-1445. doi: 10.1016/j.jtcvs.2017.07.048. Epub 2017 Aug 5.

引用本文的文献

1
Machine learning-enabled prediction of bone metastasis in esophageal cancer.基于机器学习的食管癌骨转移预测
Front Med (Lausanne). 2025 Jun 30;12:1620687. doi: 10.3389/fmed.2025.1620687. eCollection 2025.
2
[Surgical outcomes in patients with esophageal cancer in a third level center].[三级中心食管癌患者的手术结局]
Rev Med Inst Mex Seguro Soc. 2025 Mar 3;63(2):e6323. doi: 10.5281/zenodo.14616876.
3
TAPI-1 Exhibits Anti-tumor Efficacy in Human Esophageal Squamous Cell Carcinoma Cells via Suppression of NF-κB Signaling Pathway.
TAPI-1 通过抑制 NF-κB 信号通路在人食管鳞癌细胞中显示出抗肿瘤功效。
Dig Dis Sci. 2024 Jan;69(1):81-94. doi: 10.1007/s10620-023-08181-z. Epub 2023 Nov 26.
4
Prognostic impact of desmoplastic reaction in esophageal squamous cell carcinoma patients with neoadjuvant therapy.新辅助治疗后食管鳞癌患者间质反应的预后影响。
Esophagus. 2023 Jul;20(3):474-483. doi: 10.1007/s10388-023-00996-z. Epub 2023 Mar 14.
5
The role of Fbxo5 in the development of human malignant tumors.Fbxo5在人类恶性肿瘤发生发展中的作用。
Am J Cancer Res. 2022 Apr 15;12(4):1456-1464. eCollection 2022.
6
Pro-Angiogenesis Role of LINC00662 From Esophageal Squamous Cell Carcinoma Cells-Derived Extracellular Vehicles.食管鳞状细胞癌细胞衍生的细胞外囊泡中LINC00662的促血管生成作用
Front Bioeng Biotechnol. 2022 Apr 1;10:772514. doi: 10.3389/fbioe.2022.772514. eCollection 2022.
7
LINC00114 stimulates growth and glycolysis of esophageal cancer cells by recruiting EZH2 to enhance H3K27me3 of DLC1.LINC00114 通过募集 EZH2 来增强 DLC1 的 H3K27me3，从而刺激食管癌细胞的生长和糖酵解。
Clin Epigenetics. 2022 Apr 12;14(1):51. doi: 10.1186/s13148-022-01258-y.
8
Co-expression of VEGF-C and survivin predicts poor prognosis in esophageal squamous cell carcinoma.血管内皮生长因子-C（VEGF-C）与生存素的共表达预示食管鳞状细胞癌预后不良。
Transl Cancer Res. 2021 Jan;10(1):210-222. doi: 10.21037/tcr-20-2498.
9
CircGOT1 promotes cell proliferation, mobility, and glycolysis-mediated cisplatin resistance via inhibiting its host gene GOT1 in esophageal squamous cell cancer.环状 RNA GOT1 通过抑制其宿主基因 GOT1 促进食管鳞癌细胞的增殖、迁移和糖酵解介导的顺铂耐药性。
Cell Cycle. 2022 Feb;21(3):247-260. doi: 10.1080/15384101.2021.2015671. Epub 2021 Dec 17.
10
LncRNA TUSC8 suppresses the proliferation and migration of esophageal cancer cells by downregulation of VEGFA.长链非编码RNA TUSC8通过下调VEGFA抑制食管癌细胞的增殖和迁移。
J Cancer. 2021 Sep 3;12(21):6393-6400. doi: 10.7150/jca.57814. eCollection 2021.